SCHEMBL17848939

SCHEMBL17848939

CC(C)C(=O)N(N)C(=O)c1cnn2cccnc12

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 9/20 0.46
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 2/20 0.45
LMNA P02545 2/20 0.45
HSD17B10 Q99714 2/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HPGD P15428 1/20 0.45
HTT P42858 1/20 0.44
STING1 Q86WV6 1/20 0.44
PKM P14618 1/20 0.44
HSD11B1 P28845 1/20 0.44
SMPD3 Q9NY59 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17321392 0.82 HTT (0.51) IRAK4KDM4EALDH1A1LMNAHSD17B10
SCHEMBL17848875 0.82 ALDH1A1 (0.47) IRAK4KDM4EALDH1A1LMNAHSD17B10
SCHEMBL4940332 0.79 IRAK4 (0.56) IRAK4KDM4EALDH1A1LMNAHSD17B10
SCHEMBL30579396 0.75 IRAK4 (0.53) IRAK4KDM4EALDH1A1LMNAHSD17B10
SCHEMBL20250777 0.75 HSD17B10 (0.53) IRAK4KDM4EALDH1A1LMNAHSD17B10
SCHEMBL10042194 0.74 HTT (0.58) IRAK4KDM4EALDH1A1LMNAHSD17B10
SCHEMBL946897 0.74 IRAK4 (0.68) IRAK4KDM4EALDH1A1NPC1RAB9A
SCHEMBL309036 0.74 IRAK4 (0.58) IRAK4KDM4EALDH1A1LMNAHSD17B10
SCHEMBL9728912 0.74 HSD17B10 (0.52) IRAK4KDM4EALDH1A1LMNAHSD17B10
SCHEMBL18717545 0.73 PDE2A (0.61) IRAK4KDM4EALDH1A1LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233863-A1 FUSED RING HETEROARYL COMPOUNDS AND THEIR USE AS TRK INHIBITORS CMG Pharmaceutical Co., Ltd. (KR) 2017-10-25 EP disclosed
WO-2016097869-A1 FUSED RING HETEROARYL COMPOUNDS AND THEIR USE AS TRK INHIBITORS CMG PHARMACEUTICAL CO., LTD. (KR) 2016-06-23 WO disclosed